NASDAQ:SURF
Surface Oncology, Inc.
- Stock
Last Close
1.08
07/09 20:00
Market Cap
65.08M
Beta: 1.69
Volume Today
1.46M
Avg: 193.71K
PE Ratio
−0.69
PFCF: −0.78
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | -168K - | -1.45M 765.18% | -1.67M 14.76% | -481K 71.16% | ||||
average payables | 3.03M - | 3.31M 9.36% | 3.40M 2.55% | 2.53M 25.57% | 1.61M 36.26% | 903K 43.98% | ||
average receivables | 2.82M - | 298.50K 89.41% | 329.50K 10.39% | 1.45M 341.12% | 1.67M 14.76% | 481K 71.16% | ||
book value per share | 1.12 - | -0.97 187.16% | 5.15 629.36% | 2.03 60.46% | 4.38 115.39% | 2.69 38.67% | 1.68 37.67% | |
capex per share | -0.04 - | -0.10 136.00% | -0.10 1.01% | -0.06 45.33% | -0.00 97.81% | -0.00 124.20% | -0.01 228.62% | |
capex to depreciation | -2.53 - | -2.05 18.97% | -1.50 26.77% | -0.86 42.52% | -0.03 97.01% | -0.08 197.03% | -0.36 375.02% | |
capex to operating cash flow | -0.02 - | 0.16 886.80% | 0.15 3.86% | 0.03 83.25% | -0.00 105.61% | 0.00 234.28% | 0.01 333.58% | |
capex to revenue | -0.13 - | -0.15 22.03% | -0.03 77.91% | -0.10 194.67% | -0.00 99.66% | -0.04 13,003.09% | -0.02 62.90% | |
cash per share | 4.09 - | 3.27 20.01% | 11.74 258.71% | 3.78 67.85% | 4.93 30.51% | 3.48 29.29% | 2.24 35.75% | |
days of inventory on hand | ||||||||
days payables outstanding | ||||||||
days sales outstanding | 295.32 - | 7.80 97.36% | 1.98 74.55% | 7.98 302.40% | 7.44 6.84% | 103.92 1,297.08% | 2.40 97.69% | |
debt to assets | 0.07 - | 0.12 81.72% | -0.18 247.32% | 0.19 207.71% | 0.23 19.34% | 0.30 32.34% | 0.35 16.70% | |
debt to equity | 0.30 - | -0.52 273.04% | -0.30 42.47% | 0.44 247.92% | 0.32 28.41% | 0.48 52.36% | 0.60 24.47% | |
dividend yield | ||||||||
earnings yield | -0.07 - | -0.18 160.00% | -0.08 55.79% | -1.01 1,200.48% | 0.18 117.85% | -0.38 307.97% | -1.43 280.10% | |
enterprise value | 247.79M - | 235.33M 5.03% | -74.07M 131.48% | 30.65M 141.38% | 202.56M 560.87% | 212.75M 5.03% | 50.85M 76.10% | |
enterprise value over ebitda | -14.02 - | -5.23 62.72% | 8.09 254.88% | -0.53 106.60% | 3.29 715.59% | -2.80 185.09% | -0.82 70.63% | |
ev to operating cash flow | 5.98 - | -18.94 416.62% | 5.60 129.57% | -0.51 109.10% | 6.75 1,424.96% | -3.41 150.53% | -0.85 74.98% | |
ev to sales | 37.36 - | 18.35 50.89% | -1.25 106.79% | 2.00 260.07% | 1.61 19.54% | 79.18 4,831.26% | 1.70 97.86% | |
free cash flow per share | 2.10 - | -0.74 135.48% | -0.76 2.42% | -2.21 190.44% | 0.84 138.06% | -1.41 267.54% | -1.08 23.72% | |
free cash flow yield | 0.16 - | -0.06 135.48% | -0.18 222.00% | -1.18 555.02% | 0.09 107.74% | -0.30 423.86% | -1.31 344.64% | |
graham net net | 0.34 - | -1.90 656.49% | 8.19 531.32% | 1.08 86.76% | 3.22 196.66% | 1.86 42.13% | 1.05 43.79% | |
graham number | 4.76 - | 7.16 50.54% | 6.18 13.72% | 9.33 50.99% | 12.83 37.46% | 10.42 18.77% | 6.64 36.25% | |
income quality | -2.37 - | 0.27 111.54% | 2.00 632.14% | 1.10 45.23% | 0.51 53.94% | 0.79 57.13% | 0.94 17.90% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 27.38 - | -30.75 212.29% | -36.03 17.18% | |||||
interest debt per share | 0.33 - | 0.50 50.83% | -1.54 404.55% | 0.90 158.48% | 1.45 61.24% | 1.35 6.78% | 1.04 23.35% | |
inventory turnover | ||||||||
invested capital | 0.30 - | -0.52 273.04% | -0.30 42.47% | 0.44 247.92% | 0.32 28.41% | 0.48 52.36% | 0.60 24.47% | |
market cap | 257.78M - | 257.78M 0% | 84.76M 67.12% | 52.37M 38.22% | 328.44M 527.18% | 211.48M 35.61% | 45.72M 78.38% | |
net current asset value | 16.60M - | -28.92M 274.21% | 93.40M 422.94% | 32.90M 64.78% | 119.12M 262.07% | 85.40M 28.31% | 62.63M 26.66% | |
net debt to ebitda | 0.57 - | 0.50 11.82% | 17.36 3,380.39% | 0.38 97.82% | -2.04 639.91% | -0.02 99.19% | -0.08 398.74% | |
net income per share | -0.90 - | -2.35 160.00% | -0.33 85.94% | -1.90 476.63% | 1.67 187.73% | -1.80 207.59% | -1.17 34.79% | |
operating cash flow per share | 2.14 - | -0.64 130.00% | -0.66 2.97% | -2.16 226.44% | 0.84 139.09% | -1.41 266.97% | -1.07 24.21% | |
payables turnover | ||||||||
receivables turnover | 1.24 - | 46.81 3,687.45% | 183.95 292.98% | 45.71 75.15% | 49.07 7.34% | 3.51 92.84% | 152.28 4,235.60% | |
research and ddevelopement to revenue | 3.09 - | 3.73 20.57% | 0.88 76.29% | 3.39 284.07% | 0.33 90.42% | 19.94 6,032.31% | 2.23 88.80% | |
return on tangible assets | -0.18 - | -0.56 213.25% | -0.04 93.20% | -0.40 961.97% | 0.27 167.90% | -0.42 252.36% | -0.41 1.92% | |
revenue per share | 0.34 - | 0.66 93.40% | 2.97 348.13% | 0.55 81.45% | 3.55 543.66% | 0.06 98.29% | 0.54 785.87% | |
roe | -0.81 - | 2.41 398.28% | -0.06 102.66% | -0.94 1,358.46% | 0.38 140.73% | -0.67 275.42% | -0.70 4.62% | |
roic | -0.64 - | 5.09 892.48% | -0.18 103.46% | -0.55 210.30% | 0.25 146.63% | -0.37 244.97% | -0.35 4.31% | |
sales general and administrative to revenue | 0.62 - | 0.86 37.67% | 0.27 68.55% | 1.34 395.88% | 0.19 86.08% | 9.35 4,908.19% | 0.83 91.14% | |
shareholders equity per share | 1.12 - | -0.97 187.16% | 5.15 629.36% | 2.03 60.46% | 4.38 115.39% | 2.69 38.67% | 1.68 37.67% | |
stock based compensation to revenue | 0.20 - | 0.37 81.03% | 0.09 76.08% | 0.39 344.22% | 0.06 84.22% | 3.18 5,067.52% | 0.24 92.43% | |
tangible asset value | 21.57M - | -18.80M 187.16% | 102.86M 647.23% | 56.67M 44.91% | 155.75M 174.85% | 118.90M 23.66% | 93.40M 21.44% | |
tangible book value per share | 1.12 - | -0.97 187.16% | 5.15 629.36% | 2.03 60.46% | 4.38 115.39% | 2.69 38.67% | 1.68 37.67% | |
working capital | 76.97M - | 47.95M 37.71% | 137.42M 186.62% | 88.65M 35.49% | 162.86M 83.70% | 137.32M 15.68% | 112.88M 17.80% |
All numbers in USD (except ratios and percentages)